financetom
Business
financetom
/
Business
/
Advantage Energy Swings to a Q3 Loss on Low Natural Gas Prices; Trims Its 2024 Capital Budget
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Advantage Energy Swings to a Q3 Loss on Low Natural Gas Prices; Trims Its 2024 Capital Budget
Nov 3, 2024 11:13 AM

05:35 PM EDT, 10/24/2024 (MT Newswires) -- Advantage Energy ( AAVVF ) on Thursday said it swung to a loss in the third quarter and cut its capital budget on weaker natural gas prices.

The natural-gas focused Western Canadian producer said it lost $6.49 million, or $0.04 per share, in the quarter compared with a year-prior profit of $28.31 million, or $0.16. Adjusted funds flow fell to $52.26 million, or $0.31 per share, from $81.86 million, or $0.48

Revenue edged down $139.84 million from $140.72 million, as it produced 74,371 barrels of oil equivalent per day in the quarter, up from 64,195, while its average gross profit per barrel equivalent fell to $10.77 from $16.14. as its average natural-gas price fell 44% to $1.65 per thousand cubic feet.

The company said it is cutting its capital budget for the year by $15 million to a range of $245 million to $275 million "by deferring drilling and completions on certain wells that had previously been planned for the second half of 2024".

Advantage shares closed up $0.06 to $9.18 on the Toronto Stock Exchange.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
AbbVie Closes Aliada Therapeutics Acquisition
AbbVie Closes Aliada Therapeutics Acquisition
Dec 11, 2024
09:37 AM EST, 12/11/2024 (MT Newswires) -- AbbVie ( ABBV ) said Wednesday it has closed the acquisition of Aliada Therapeutics. The company in October agreed to acquire Aliada Therapeutics for $1.40 billion in cash. Price: 174.85, Change: -0.82, Percent Change: -0.47 ...
European Biotech Pharming Group Touts Positive Data From Pivotal Pediatric Study Of FDA-Approved Immune System Disorder Drug
European Biotech Pharming Group Touts Positive Data From Pivotal Pediatric Study Of FDA-Approved Immune System Disorder Drug
Dec 11, 2024
On Wednesday, Pharming Group N.V. ( PHAR ) revealed topline results of data from its Phase 3 trial evaluating leniolisib in children aged 4 to 11 years with activated phosphoinositide 3-kinase delta syndrome (APDS). APDS is a genetic disorder that impairs the immune system. Individuals with this condition often have low numbers of white blood cells, particularly certain types of...
Arthur J. Gallagher Buys Sheila J. Butler & Co.
Arthur J. Gallagher Buys Sheila J. Butler & Co.
Dec 11, 2024
09:34 AM EST, 12/11/2024 (MT Newswires) -- Arthur J. Gallagher ( AJG ) said Wednesday it has bought Georgia-based employee benefits brokerage firm Sheila J. Butler & Co. Financial terms weren't disclosed. Price: 284.17, Change: +0.43, Percent Change: +0.15 ...
Evergold's DEM Prospect Returns High Grades of Antimony in Drilling; Shares down 12%
Evergold's DEM Prospect Returns High Grades of Antimony in Drilling; Shares down 12%
Dec 11, 2024
09:39 AM EST, 12/11/2024 (MT Newswires) -- Evergold ( EVGUF ) on Wednesday announced assay results for two core holes (DEM24-04 and DEM24-05) completed on the DEM Mountain Zone near Fort St. James, B.C. in early Oct., in follow up to highly encouraging results from an initial 3-hole drill program (DEM23-01,02,03), carried out in fall 2023. The company said the...
Copyright 2023-2025 - www.financetom.com All Rights Reserved